Singapore, Aug. 4 -- PhnyX Lab, a pioneering GenAI startup transforming how life science companies operate, has announced the successful closing of a$4 millionseed round through a Simple Agreement for... Read More
Singapore, Aug. 4 -- However, conventional manufacturing approaches face significant hurdles: plasmid-based transfection is often inefficient due to DNA-induced toxicity, while viral vectors carry inh... Read More
Singapore, Aug. 4 -- VB Spine LLC, a global, family-led spine company dedicated to advancing patient outcomes, has announced the completion of the sale of Stryker's spinal implants business in Austral... Read More
Singapore, Aug. 4 -- A unified consensus document for improving lung cancer care in the Asia-Pacific(APAC) region has been officially launched in Singapore, marking a pivotal moment in the regional fi... Read More
Singapore, Aug. 4 -- The Department of Rehabilitation Sciences at The Hong Kong Polytechnic University (PolyU) recently hosted the inaugural Clinical Education Conference, the first event of its kind ... Read More
Singapore, Aug. 4 -- Scientists have launched the first-ever library of adjuvants - substances that could boost the performance of vaccines tackling some of the world's deadliest diseases. The UK's M... Read More
Singapore, July 31 -- The Hong Kong University of Science and Technology (HKUST) and Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan Union Hospital) have j... Read More
Singapore, July 31 -- Japan-headquartered Shimadzu Corporation and Kyoto University have signed a comprehensive collaborative agreement with the objective of creating new business activities and innov... Read More
Singapore, July 30 -- South Korea-based Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX has entered into a co-development and license agreement valu... Read More
Singapore, July 30 -- Viridian Therapeutics, Inc., a US-based biopharmaceutical company focused on discovering, developing, and commercialising potential best-in-class medicines for serious and rare d... Read More